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We have used the polymerase chain reaction and Northern 
blotting to identify protein tyrosine kinases that may play an 
important role in the proc~ss of melanoma initiation and 
rogression. Degene~ate ~nmers from the conserved ca~a­
fytiC domain of tyrosme kmase genes were used to amphfy 
and clone partial eDNA sequences from a human melanoma 
e ll line (DX3-LT5.1) and normal human melanocytes. 
When the melanoma reaction products were sequenced, 13 
distinct clones were found, of which one is novel t? da.te and 
has provisionally been named MEK (for melanocyttc kmase). 
Of the remaining 12 known kinases, only two, ERB-B2 and 
ICF1-R, have previously been reported in pigment cells. Re-
action products from melanocytes included only eight of 
these 13 sequences. To test for quantitative differences in 
T he superficial and pigmented nature of cutaneous melanomas and their accessibility have allowed a de-tailed characterization of this lesion at multiple stages of development, resulting in its becoming an attrac-tive model of oncogenesis [1]. One general approach 
the study of this system has been to use a panel of melanoma cell ~fnes , and to identify changes in gene expression that correlat.e with 
d'fferentiation and metastatic propensity [2,3). Protem tyrosllle b-n~ses (PTKs) playa key role in the c~)11trol of cell proliferation and 
di fferentiation. These protellls are either tral~smembrane rec~pto~s 
for polypeptide growth factors, or cytoplasmic k111ases often Imph-
, ated in signal transduction from other receptors. They IIlclude ~any oncogene products, several in the receptor subfamily [4]. On-
genes can arise by structural alterations ofPTK receptors, such as 00 . . I truncation of the extracellular region, or mutations m t le trans-
membrane or cytoplasmic domains [5]. Human melanoc:ytes re-
spond to several growth factors whose receptors have tyrosme b-
ase activity. These IIlciude baSIC fibroblast growth factor (bFGF or ~GF2, with receptor FLG); insulin-like growth factor 1 (IGF-1, 
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tyrosine kinase expression between normal and malignant 
cells, a panel of eight melanoma lines and normal melano-
cytes was analyzed by Norther.n blotting. Two tyrosine ki-
nases (}TK-14/ TIE and TYRO-9) were detected in some 
melanomas but were not f~und in normal melanocytes, 
whereas others, including MEK, appeared to be overex-
pressed in some malignant lines. A minority of kinases 
showed either no change or a reduction in the level of 
mRr:'lA: ~xpression of tyrosine kinases varied independently, 
and l11dlvldualll11es contained various combinations of these 
enzymes. Our findings are consistent with an increased over-
all expression of these putative growth factor receptors dur-
ing melanoma development. Key words: melanocytes/ 
growth factors/PeR.] Invest Dermatoll01 :679 -684, 1993 
receptor IGF1-R); stem cell factor (SCF, receptor KIT), and hepato-
cyte growth factor (HGF, receptor MET) [6 -8]. KIT and MET are 
proto-oncogenes, and KIT is crucial for melanocyte development, 
111 that few or no melall0cytes are present in the coat of mice homo-
zygous for W mutations, which impair this receptor [7]. A role for 
PTKs in melanoma is supported by various lines of evidence. Mela-
nomas commonly show overexpression of the epidermal growth 
factor receptor (EGF-R or ERB-B), in association with an extra copy 
of chromosome 7 (the location for EGF-R and the related ERB-B2) 
[9] . The well-known inherited melanoma oncogene in fish of the 
genus Xiphophorus is a PTK in the ERB-B family [10] . Moreover, 
transgenic mice ectopically expressing Ret. a PTK closely related to 
KIT, develop benign melanocytic tumors [11]; and the further se-
lection of a metastatic n?elanoma cell line from these benign tumor 
cells was associated WIth an 1I1creased tyrosine phosphorylation 
[12J. Recent unmunologlc data have suggested that there is an in-
creased level of tyrosine phosphorylation in protein ex tracts from 
melanomas as compared to melanocytes [7]. This does not appear to 
result f~om a decreased phosphotyrosine phosphatase activity [8], 
suggest111g that there may be an lI1creased PTK activity in melano-
mas. 
The insertion of some PTK oncogenes into murine fibroblasts has 
resulted in acqu.isition of a metastatic phenotype [13]. In this regard 
PTKs may ~ledlate motl!tty, chemotaxis, or responses to organ-spe-
CIfic paracnne growth factors [14]. The highly conserved nature of 
the catalytic domain of this large gene family has facilitated the 
IsolatIon of PTK genes by polymerase chain reaction (PCR) using 
hi ~l:ly degenerate ~rimers [15] . Therefore, as a step towards deter-
m111mg the repertoIre of PTK expression by pigment cells, and any 
alterations in melanoma, we have used PCR to perform a compara-
tive survey of PTKs expressed by cultured normal and malignant 
pigment cells. This was followed by a quantitative analysis of ex-
pressIon of some of these ge nes by Northern blotting. Most of the 
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kinases studi ed showed abnormal expression, usually overexpres-
sion, in m elanomas as compared to melanocytes. We also report a 
novel PTK found in both melanocytes and melanomas. 
MATERIALS AND METHODS 
Culture of Melanocytes and Melanomas Normal melanocytes were 
iso lated from newborn human foreskins and cultured according to the 
mcthod of Eisinger and Marko [16), with modifications as previously de-
scribed [17]. Of the melanoma cell lines, DX3-LT5.1 is a subclone of 
SKMEL93-DX3 and was kindly provided by Dr. Ian Hart (Imperial Cancer 
Research Fund, London, UK); RPMI-7932 was a gift from Prof. George 
Moore, Department of Health and Hospitals, Denver, Colorado. DX3-
L T 5.1 was derived from the poorly metastatic parental line after a brief 
exposure to 5-azacytidine and repeated passage through the lungs of nude 
mice to derive a highly metastatic ccll line [18]. Melanoma cell Lines 
WM239A, WM164, and ML [19,20] were maintained in W489 medium 
with 2% fetal bovine serum (FBS), whereas lines WM1158, SKMEL23, 
DX3-LT5.1, RPMI-7932, and WM9 [18,21 ,22] were grown in Dulbecco's 
modification of Eagle's medium supplemented with 5% FCS. Rectal carci-
noma ceillinc SW620 [23] was included as a control and grown in W489 
medium with 2% FBS. 
cDNA Synthesis Total RNA was isolated from cell lines using the guani-
dinium isothiocyanate/ caesium chloride procedure [24]. Poly(A}+ RNA was 
selected by two cycles of oligo(dT}-cellulose chromatography [25]. First-
strand cDNA was prepared using 10 Ilg of poly(A}-enriched RNA from cell 
line DX3-LT5 .1 or from foreskin mclanocytes. RNA was heated to 70°C 
for 3 min and then placed on icc. Reverse transcription was from oligo(dT} 
using a cDNA synthesis kit (Pharmacia, Central Milton Keynes, U.K.). 
PCR PC R was used to amplify PTK-related sequences from single-
stranded cDNA using degenerate primers coding for the amino acid residues 
HRDLAARN (upstream) and DVWS(F/Y)G(V /I} (downstream), as de-
scribed by Lai and Lemke [26]. Approximately 10 ng of cDNA was used in 
each amplification. Taq polymerase reaction conditions were as recom-
mended by the supplier (Perkin-Elmer Cetus Corporation, CAl. Amplifica-
tion was as follows: 5 min at 94 °C, then (1 min at 94 °C, 1 min at 37 °C, 1 
min at n °e) for 5 cycles, and (1 min at 94 °C, 1 min at 55°C, and 1 min at 
72 0 C) for 25 cycles , with a final extension step of 10 min at 72 ° C. Target 
cDNA was added before heating. The unusually low initial annealing tem-
perature employed here favors amplification of a broader range ofPTKs [26] 
than those obtained with previous protocols [15] . 
Subcloning of PCR Reaction Products PCR products were blunt-
ended using T4 DNA polymerase and phosphorylated by T4 polynucleotide 
kinase. Approximately 10 ng of insert was then ligated with 250 ng of 
dcphosphorylated SlIIaI-digested pUC18 plasmid, and the product was used 
to transform competent DH5a bacteria. 
Dot-Blot Analysis Dot-blot analysis of the melanocyte PCR clones in 
pU C1S was performed using a manifold apparatus. Subcloned PTK se-
quence fragments from melanoma cells were excised for use as probes, as 
previously described [26] . Probes were labeled by random hexamer priming 
[27] to a specific activity of about 2 X 109 dpm/Ilg DNA. Prehybridization 
was at 65 °C for 2 h in 6 X SSC (1 X sodium citrate/sodium chloride buffer 
(SSe) is 0.15 M sodium chloride, 0.015 M sodium citrate), 5 X Denhardt's 
solution (1 X Denhardt's solution is 200 Ilg/ml bovine serum albumin, 200 
Ilg/ml Ficoll, and 200 Ilg/ml polyvinyl pyrrolidone), 100 Ilg/ml denatured 
salmon sperm, and 1% w/v sodium dodecyl sulphate (SDS), at 65 °C. Hy-
bridization was in the same solution for 12 h. Filters were washed to a high 
final stringency of 0.1 X SSC and 0.1 % SDS at 65°C and autoradiographed 
at - 70 ' C. 
DNA Sequencing Subcloned PCR products in pUCIS were restricted 
with BatnHI and EeaRI , and the complete sequence determined for all clones 
of the expected size (220 bp). Both strands were sequenced using alkaline 
lys is miniprep DNA [28[ and the Sequenase procedure (USB, Cleveland, 
OH). Sequences were compiled using the Intelligenetics GEL program and 
compared to the EMBL gene bank and PIR database with the Intelligenetics 
IFIND software. Amino acid sequences were deduced from the Ilucleotide 
sequences of the 13 different PTKs found in this study. 
Northern Blotting Analysis Aliquots (10 Ilg) of poly(A}-enriched RNA 
were subjected to agarose gel electrophoresis. Bands were transferred to 
nitrocellulose membranes, prehybridized, and then hybridized with PTK 
probes prepared as above. The probe for KiT was a gift from Dr. Ed Geissler 
(Harvard University Medical School, Boston, MA) and was used here as a 
pos itive control for PTK expression in melanocytes. Prehybridization (4 h) 
and hybridization (18 h) were at 42 °C in 5 X SSC, 5 X Denhardt's solution, 
50% w/ v formamide, 100 Ilg/ml salmon sperm DNA, and 1% SDS. The 
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final wash was in 0.1 X SSPE and 0.1% 50S at 65 °C. After washing, filters 
were autoradiographed for 5 -12 d at - 70°C with two intensifying screens. 
The molecular weights of hybridizing bands were determined by compari-
son with molecular weight markers (Pharmacia). For normalization of RNA 
loading, blots were rehybridized with genes for housekeeping proteins gly-
ceraldehyde phosphate dehydrogenase (GAPDH) (a gift from Professor 
Mike Clemens, St. George's Hospital Medical School), and a a-enolase [3]. 
Exposure after hybridization with the GAPDH probe was for 3 h. For PTK 
quantitation, autoradiographs were scanned by laser densitometry using 
Image Quant software, version 3.2 (Molecular Dynamics, Sunnyvale, CAl. 
The relative level of expression of each PTK transcript was calculated as the 
ratio of signal in the area of the band for that transcript to that for the 1.3 kb 
GAPDH transcript in the same cell line. Figures for each PTK were then 
normalized to the level in one specified cell line (defined as 100). 
RESULTS 
PCR Cloning of PTKs from Pigment Cell Lines peR was 
used to amplify PTK-related sequences, initially from a human 
metastatic melanoma cell line (DX3-L T5 .1). Because we are partic-
u larly interested in growth factor receptors, the oligomeric primers 
used were chosen to correspond to sequences that are highly con-
served in receptor PTKs, with less homology to cytoplasmic PTKs 
[26]. The fragment to be amplified from PTKs was approximately 
220 bp of the catalytic domain. One hundred thirty-five cloned 
fragments of this size were sequenced. A computer search for se-
quence identity or homology in the EMBL and Genbank databases 
showed that 51 of these were from PTKs. There were 13 distinct 
sequences. One represented a novel PTK, which has provisionally 
been named MEK (melanocytic kinase) . When the peR product for 
MEK was used to screen a eDNA library made from normal human 
mclanocytes (kindly provided by Dr. Byoung Kwon, Indiana Uni-
versity, Indianapolis, IN), clones providing a continuous sequence 
of 2.1 kb were isolated. This partial sequence is consistent with 
MEK's being a new receptor-type PTK (to be described separately) . 
The PTK sequences detected in melanoma cells are listed by 
family homology in Table 1, with the frequency of detection of 
Table I. Incidence of Different PTKs Among Sequenced 
peR Clones 
Incidence' 
Melanocytes Melanoma 
Family Kinase n % n % 
Receptors 
EPH TYRO-6 8 36 5 10 
ECK 4 18 9 18 
TYRO-4 0 0 1 2 
FGF-R FGF-R4/TKF 4 18 6 12 
TYRO-9 0 0 3 6 
INS-R IGFI -R 2 9 4 8 
1YRO-3 TYRO-3b 1 4.5 6 12 
TYRO-tO TYRO-I0 1 4.5 3 6 
EGF-R ERn-B2 0 0 5 10 
JTK-14 JTK-14 0 0 2 4 
Cytoplasmic 
CSK CSK/TYRO-13 1 4.5 3 6 
FES FES 0 0 1 2 
Novel 
[receptor?] MEK' 4.5 3 6 
41 The observed incidences arc given as absolute numbers (n) and as a percentage o f aU 
PTK clones derived from that cell eype. However, it should be emphasized that this 
gives little information on the original relative abundances of transcripts. as oth~r 
factors contribute to the frequency of amplification by PCR. 
I The deduced partial amino acid sequence for human TYRO-3 is as follows. This 
sequence corrcsponds to PTK subdomains VI-IX. One glut3Jninc residue seen in all 
clones differs from the published rat sequence and is doubly underlined. The amino acid 
sequences corresponding to peR primers are underlined: HRDLAARNCMLAEDMT 
VCV AFG LSRKlYSG DYYRQGCASKLPVKWLALESHADNL YTVQSDVWSFG 
V. ----
' The corresponding deduced partial amino acid sequence for MEK is as follow<: 
I-IRDLAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 
NFRRFTSASDVWSFGV. 
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each, and the sequences of the PeR-derived fragments for human 
TYRO-J and MEK (see below). The closest homolog to the MEK 
peR sequence was the PTK gene LYN, at 64% identity. Of the 12 
known kinases, two, FES and TYRO-13/ CSK, were cytoplasmic 
[29,30]. This is consistent with our primers' lacking an abso l ~te 
specificity for receptor PTKs [26]. The 10 known receptors tn-
cluded only two receptors for known ligands: the insulin-like 
growth factor-1 receptor (IGF1-R) [31], and ERB-B2 or NEU, a 
receptor for a family ofligands including glial gr~wth factors, "neu 
differentiatIOn factors" and others [32]. The rematntng eight recep-
tors for unknown ligands were less familiar, and mostly described 
during the course of this study [26,33 - 35]. The deduced amino acid 
sequences for human TYRO genes were identical to those for rat 
clones [26], except that in our sequence for TYRO-3 (Table 1) there 
was a glutamine residue in place of the histidine reported in the rat 
homolog [26] at amino acid residue 60 (counting the histidine in the 
conserved motif HRDLAARN as residue 1). 
We then repeated the entire procedure with cDNA from normal 
human melanocytes. Products of this peR were cloned and ana-
lyzed by a combination of dot blotting and sequencing. For dot 
blotting, PTK fragments already cloned from DX3-LTS.1 were 
used as probes on filters made from melanocyte products. Washing 
was to a high stringency to restrict hybridization to sequences iden-
tical to the probes. Analysis of 120 clones from melanocytes re-
vealed 22 clones with identity to PTKs from the melanoma. The 
remaining 98 non-hybridizing clones were analyzed by a combina-
tion of cross-hybridization and sequencing. No furth er PTKs were 
fo und, however. A total of eight distinct PTK sequences were iden-
tified in melanocytes, including CSK/TYRO-13 (cytoplasmic), 
MEK, and six other receptors: TYRO-6, ECK, FGF-R4, IGF1-R, 
TYRO-J and TYRO-10 (Table 1). 
Northern Blotting Analysis ofPTKs The peR method does 
not provide quantitative information on relative expression. To test 
for quantitative differences between normal and malignant lines, 
poly(A)+-enriched RNA from eight melanoma.lines, one colorectal 
carcinoma line, and normal melanocytes was Isolated and used to 
perform Northern blotting with probes for most of the less familiar 
PTKs detected by PCR, and for KIT. The results are shown in Figs 
1- 3 and summarized quantitatively in T able II. The sizes for 
known PTK mRNAs found by blotting are indicated, and are con-
sistent with those reported previously [25,32-34] . The probe for 
the novel clone MEK detected an RNA of 5.2 kb (Fig 2). The results 
of densitometry cannot be used to compare the level of different 
mRNAs within a cell line. However, a comparison of signal intensi-
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Figure 1. Northern blot analysis of poly(A)+-enriched RNA from melano-
mas and melanocytes (10 Ji g/laue) to PeR-derived probes for ECK, KIT, and 
JTK-1 4. Two independent experiments arc shown. The blots hybridized 
with ECK, KIT, andJTK-1 4 were exposed for 1, 14, and 1 day(s), respec-
tively. 
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Figure 2. Northern blot analys is of poly(A)+-enriched RNA from melano-
mas and mclatwcytes (10 Jlg/lat/e). Hybridization was to MEK and GAPDH 
probes. Two. ttldependent experiments are shown. The lower molecuJar-
weight band ttl the MEK panel represents residual signal from the previous 
hybri~ization, with the prob~ for JTK-14 (left gel) or TYRO-6 (right gel). 
(Note. a less-exposed autoradlOgraph was used for laser densitometry, cna-
blttlg scannttlg of theMEK band alone.) The durations of exposure were 5 d 
for MEK and 1 h for GAPDH. 
ties and times of exposure suggested that the level s of mRNAs for 
most of the PTKs analyzed in this study are very low compared to 
those for the housekeepmg genes GAPDH (Fig 2) and a -enolase 
(data not shown). In accordance with this, PTK sequences were not 
detected on blots of total RNA. However, ECK and TYRO-9 were 
detecte~strongly after exposures of only 8 and 12 h, respectively, in 
poly(A) -enriched RNA from some melanomas. One mRNA de-
tected by PCR, TYRO-4, was not detected by Northern blotting, 
even for melanoma DX3-L T5.1 fo llowing extended autoradiogra-
phy. Tll1s probably refl ects a very low abundance, and is consistent 
wi th the high sensitivity of peR in analysis of transcription. 
Most PTK genes showed some variation in levels of mRNA be-
tween different melanom~s a l~d the melanocytes (Table II) , in other 
words, abnormal expressIOn m some melanomas. A variety of dif-
ferent patterns of expression were observed for different PTKs (see 
DisCllssioll ). 
DISCUSSION 
Spec~6.c PTK Se~uences Detected in Pigment Cells We 
have Id~nttfied 13 dtfferent PTKs, thus significantly extending the 
reper.tOlre of known PTK genes expressed in pigment cells. Of th ese 
13 k1l1ases, only ERB-B2/ NEU and IGF1-R have been reported 
previously in melanocytes or melanoma cells [14 36]. This number 
of distinct sequences is of the same order as that ~eported for other 
cell lines investigated using peR [34,35]; however, a number of 
PTK sequences were identified only once here, and others present 
were probably not det~cted by our peR analysis. For example, KIT 
and MET expression In melanocytes has been observed by other 
methods [7,8,3]; (see Results), and other workers using different 
primers for peR have detected further unreported PTKs from mel-
anocytes (R.A. Spritz, personal communication') . Some omissions 
would not be surprising, as the products of peR are influenced by 
• Lee S-T, Strunk K, Spritz RA. A survey of protein tyrosine kinase 
mRNAs expressed in normal human melanocytes. Ollcogell e (submitted for 
publication) . 
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Figure 3. Northern blot analys is of poly(A)+-enriched RNA from melano-
mas and melanocytes (10 /1/latle). Hybridization was to vartous TYRO 
probes. Two independent experiments are shown. The lower molecular 
weight band in the TYRO-9 panel represents a resIdual sl.gnal from the 
previous probe. The upper band in the TYRO-13 panel IS resIdual ~Igna l for 
JTK-14. The durations of exposure were 5, 3,1,5, and 5 d, respectIvely, for 
TYRO 3, 6, 9, 10, and 13. 
stochastic events as well as target sequence and concentration, so 
th~t (as used here) this technique is not expected to produce a quan-
titative nor necessari ly complete survey. 
We report a new member of the receptor family of PTKs, here 
designated MEK. We have learned that this sequence has also been 
detected by Spritz and colleagues; they have called It PTK-2, and 
have reserved this name as a gene locus symbol.- Nonetheless, MEK 
will be used in the present discussion for simplicity. MEK.mRNA 
was detected in all of the cell lines tested by Northern blotting, and 
it may thus encode a receptor for an. obligatory growth facto~ for 
melanocytic I ines. Further characterization of tlllS sequence IS 111 
progress. . . 
Transcription in pigment cells of a number of other 111terest111g 
PTK genes is reported here for the first time. The TYRO genes 
were originally cloned from cDNAs enriched for transcripts ex-
pressed by Schwann cells [26] , and the comparatively large number 
of TYRO sequences (TYRO-3, 4, 6, 9, 10, and 13) isolated from 
pigment cell s here, but not from cells of other types [34,35], may 
reflect the common embryologic origin of melanocytes and 
Schwann cell s. The use of the same PCR primers may also have 
contributed to the similarity of the range of PTKs observed. One 
TYRO sequence, TYRO-13, is identical to that for an intracellular 
kinase with a known function, CSK (c-src kinase). This phosphoryl-
ates the important intracellular tyrosine kinase pp60"', or SRC, on 
Tyr 527 (mouse) or 530 (human), reducing its kinase activity [30]. 
Th is is of interest here because melanomas have been reported to 
show less SRC activity and more phosphorylation of SRC at Tyr 
530 than melanocytes [37] . Thus SRC may ,inhibit proliferation in 
this lineage, as it appears to do in some neuronal cells. However, we 
did not detect significant changes in transcription of CSK between 
melanoma cells and melanocytes, suggesting that any increase in 
CSK activity in melanoma is post-transcriptional. 
Several clones for receptor ECK (epithelial cell kinase) [33] were 
isolated from both melanocytes and melanoma by peR. However, 
- Lee SoT, Strunk K, Spritz RA. A survey of protein tyrosine kinase 
mRNAs expressed in normal human melanocytes. Ollcogel1e (submitted for 
publ ication). 
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Northern blotting detected this sequence in only some of the mela-
nomas and not in melanocytes. This reflects the greater sensitivity 
of peR compared to Northern blotting, and suggests that ECK 
expression is greatly increased in some malignant lines. This could 
be important in proliferation of primary melanoma cells, as ECK 
protein has been found in skin, suggesting that the ligand may also 
be present [33] . JTK-14 was originally cloned. from a human lym-
phoma cell line, K-562, when Northern blotting analySIS detected 
expression in K-562 and another leukemic line, but not In a large 
range of other human tumor cell lines. Expression was later found in 
normal vascular endothelium and the gene was renamed TIE (tyro-
sine kinase with immunoglobulin and EGF homology domains) 
[34] . In the present study we foundJTK14/TIE expression in two 
melanomas and the colorectal carcinoma line SW620. It has been 
suggested that this receptor PTK mediates blood cell adhesion to 
the vascular endothelium [34]. If so, thenJTK14/TIE may also play 
a role in interactions between melanoma cells and blood cells or 
endothelial cells, and contribute to the process of metastasis. 
Patterns of PTK Expression in Melanoma Remarkably, 
nearly all PTKs analyzed by Northern blotting (8/9) showed ab-
normal expression in some melanomas as compared to melanocytes. 
The only exception was the intracellular PTK, TYRO-13/CSK, 
expressed at similar levels in all cell lines. The. abnormal patterns of 
expression fell into four classes,. as follows: I) One sequence was 
detected in melanocytes but not 111 metastatic melanomas, namely, 
KIT. This finding is in broad agreement with other recent studies of 
KIT transcription in melanoma [7] . Similarly, an immunocyto-
chemical study indicated KIT protein expressIOn to be restricted to 
early melanomas and to be lost on dermal invasion [38] . ii} One 
sequence, TYRO-3, was present in melanocytes and. melanomas, 
but expression was decreased 111 some melanomas relative to t.hat of 
normal melanocytes. iii) Four sequences were overexpressed 1Il one 
or more melanomas, relative to normal melanocytes, including 
MEK (overexpressed in RPMI-7932) . The other three such se-
quences were not detectable in melanocytes by Northern blotting 
(although they had been cloned from melanocytes following peR, 
indicating low levels of mRNA) , but were overexpressed (detecta-
ble by Northern blotting) in some melanomas. These were ECK, 
TYRO-6, and TYRO-10. ECK was particularly highly expressed 1Il 
some lines, including DX3-LT5.1. iv) Lastly, TYRO-9 andJTK-14 
transcripts were observed in only some melanomas, but not in mela-
nocytes (apparent ectopic expression). Thus, 8/8 receptor PTKs 
studied showed instances of abnormal expression in melanomas, 
namely, reductions in two cases and increases in six cases. Alter-
ations in the expression of these various PTKs appeared to be par-
tially independent, but interestingly some melanomas (WM1?4, 
WM 1158, and SKMEL23) showed a similar pattern of expreSSIon 
to normal melanocytes, whereas the pattern in other liens (RPM!-
7932 and WM9) seemed closer to that for DX3-L TS.1. 
It is possible that culture conditions may modify PTK express.ion. 
However, most of the observed differences cannot be explallled 
thus, because within each experiment (Table II), all tumor line 
were grown under the same conditions, yet differed extensively in 
their PTK expression. The normal melanocyte cultures were sup-
plemented with phorbol ester and cholera toxin [17], yet this cannot 
account for the differences between them and melanomas, as nearly 
every PTK was expressed in some melanomas at levels similar to 
those in melanocytes. The exceptions were KIT and TYRO-6; the 
loss of KIT expression has been confirmed in uncultured melanomas 
[38] . We have also found that cultures of the .same m.ela\1(~mas in 
each of the two melanoma media used here did not dtffer 111 PTK 
expression; that a further melanoma line grown in normal melano-
cyte medium had a markedly different pattern of PTK expressIOn 
from that of normal melanocytes, and that addition of cholera toxin 
to cultures of melanoma DX3-LTS.l did not affect PTK synthesis, 
including that of TYRO-6 (unpublished data). 
Both reductions and increases in PTK expression (including ec-
topic expression) may be of clinical interest. The reproducible 105:> 
of KIT protein expression by melanomas observed by several groups 
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Table II. Quantitation of PTK mRNA Expression in Human Melanomas and Melanocytes by Northern B lotting 
IGnase 
Cells" ECK KIT TYRO-3 TYRO-6 TYRO-9 TYRO-l a CSK JTK-14 MEK 
Experiment jl, 
WM239A 0' a 100 100 a 100 100 100 100 
SW620 100 0 21 345 100 0 86 98 103 
WM164 a 0 22 38 a 53 84 a 69 
ML 0 0 103 145 a 881 37 0 98 
. ··h Expenment 11 
28 0 12 24 a a 45 0 48 WMt158 
SKMEL23 39 0 41 69 a a 41 a 110 
LTS . l 100 0 100 100 100 100 100 100 100 
RPMI-7932 246 a 198 30 286 a 76 0 288 
WM9 21 a 120 19 68 221 41 a 51 
Normal a 100 140 0 0 a 84 0 57 
- " All cell lines arc metastatic melanomas except the colon carcinoma cell line SW620 and the nonnal mclanocytcs (Normal). Tumor lines in experiment i were grown in W4B9 
edium with 2% FCS, those in experiment ii in DMEM with 5% FCS. 
m, For experiment i,levels of expression were normalized to that in cell line WM239A (defined as 100). Where only one cell line was positive for a probe, this was defined as 100. 
Note that SW620 was the colore"al carcmoma lme. For expenment II, levels were normalized to line DX3-LT5.1 except that for KIT, defined as 100 in normal melanocytes. 0 
. ndicates that no signal was detectab le. 
I ' PTK mRNA expression was quantitated by laser densitometry of autoradiographs, and relative expression levels were normalized to GAPDH mRNA expression and to one cell 
line for each probe as described (Materials a'Jd Methods), Data arc from two Independent cxpcnlTIcnts as shown. 
supports sug.gestions that t h is prot~in may have tumor-suiJpressor 
ac tivity in p igment cell~ [7] , Its aCtIvatIOn perhaps promot1l1 ~ cell 
d ifferentiation as It does 111 mast cells [39]. Conversely, a maJorIty of 
the PTKs studied were expressed at abnormally high levels in at 
least some melanomas. This is consistent with the observation of 
elevated overall levels of tyrosine phosphorylation in melanoma 
cells [7 ,8], and suggests that PTK activity in general, especially from 
those receptors that are overexpressed in melanoma, promotes on-
cogenesis, ratl~er than opposing it, as ma~ be true for KIT. (It is clear 
that differe nt lIltracellu lar Signals can arIse from different tyrosllle 
kinase receptors.) 
This promotion. of malignancy ~ay take various forms. The 
metas tatic cascade lIlvolves the selectIOn of a subpopulatlon of cells 
wi thin a primary tumor that are capable of negotiating all of the 
numerouS stages required [40]. These include proliferation at the 
primary site, which may be promoted by PTKs likeECK, and inva-
sion of the dermis, where factors like the MET lIgand, HGF, or 
scatter factor, may contribute. Probably one requirement for suc-
cessful metastasis is that cel ls can respond to paracrine growth fac-
tors at the d istant site. The human melanoma DX3-LTS.1, used for 
the initial PCR amplification in this study, was selected for lung 
colonization after repeated passage through mouse lung [18] . Hence 
some PTKs included in classes iii and iv above may be receptors for 
paracrine lung growth factors. In this regard it is interesting that 
cwo melanomas capable of lung colonization, RPMI-7932, derIved 
from a p leural effusion [24], and DX3-LTS. l [18] have a similar 
pattern of increased PTK expression (for ECK, TYRO-6, and 
TYRO-9) compared to normal melanocytes. The parental line DX3 
is only poorly metastatic in nude mice [18]. By Northern b lotting 
analysis, we detected a much lower signal for ECK in DX3, com-
pared to that for the highly metastatic variant DX3-LTS. l (unpub-
lished data). This is also consistent with a role for ECK in metastasis . 
PTKs in these classes may also be involved in autocrine growth 
stimulation; there is evidence that melanomas can synthesize and 
show autocrine responses to some PTK ligands such as bFGF [28]. 
Lastly, overexpressio.n may lead to constitutive activity (without 
requirement for the hgand) or P!K receptors [41] . As an addltlonal 
point of interest, any PTK that IS markedly overexpressed 1Il mela-
nomas may be of some practical use as a tumor marker. 
In summary, we have reported the isolation ofMEK, a new mem-
ber of the multigene fami ly. of PTKs, which was expressed by all 
lines tested; and have detected expression of 12 additional PTKs, ten 
of which were not previously reported in melanocytic lines. Finally, 
in a study of expression of selected PTK genes in a small panel of 
malignant melanomas, we have observed abnormal transcription 
levels of most of the PTKs in some tumors, and these changes may 
contribute to tumor cell proliferation or other activities like migra-
tion. This seems worthy offurther study, and we are currently using 
immunocytochemical methods to analyze the expression of some of 
these e nzymes in cl inica l m ateriaL 
We are greatf), illdebted to oll r colleagues IU/IO supplied cell lilies (Dr. Iatl Hart, 
ICRF, LOlidoll, alld Professor George Moore, Delwer, Colorado), to Dr. ByOllllg 
KIUOII (Ilidialia Ullillersity)forthegiftofa IlIIlIIalllllela'lOcytecDNA library, to Dr. 
Ed Geissler (Harvard Ullillersity Medical School) for Ihe KIT probe, to Dr. Tibor 
Gyiirfi (The Wistar hlS/illlle) for preparillg sOllie of the melalloma RNA blots, to 
Professor Richard Spritz for sharillg data prior 10 publicatiOlt, alld to Ihe Catlcer 
Research Campaigll alld (he Imperial Callcer Research Flilld, who sllpported this 
rescllrch. 
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